Ledger.Open graph →
SEC Form D · filed May 2, 2017

InCarda Therapeutics, Inc

Offering
$2.5M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Brisbane, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Rangachari Narasimhan · Palo Alto, CAExec · DirectorMccarthy Reenie · Brisbane, CADirectorGrace Colon · Mountain View, CAExec · DirectorBischofberger Norbert · Brisbane, CADirectorMiller Samantha · Brisbane, CAExecRangachari Narasimhan · San Francisco, CAExec · DirectorMccarthy Reenie · Brisbane, CADirectorGrace Colon · Mountain View, CAExec · DirectorBischofberger Norbert · Brisbane, CADirectorMiller Samantha · Brisbane, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗